Waverton Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,000
Closed -$222K 38
2025
Q3
$222K Hold
2,000
﹤0.01% 99
2025
Q2
$222K Hold
2,000
﹤0.01% 102
2025
Q1
$224K Buy
+2,000
New +$206K ﹤0.01% 98
2018
Q2
Sell
-10,525
Closed -$793K 74
2018
Q1
$793K Hold
10,525
0.05% 65
2017
Q4
$754K Hold
10,525
0.04% 67
2017
Q3
$853K Buy
10,525
+101
+1% +$7.72K 0.05% 55
2017
Q2
$738K Sell
10,424
-1,262
-11% -$84K 0.05% 65
2017
Q1
$794K Sell
11,686
-1,011,603
-99% -$71.1M 0.05% 78
2016
Q4
$73.3M Buy
1,023,289
+35,506
+4% +$2.64M 4.8% 4
2016
Q3
$78.2M Buy
987,783
+92,512
+10% +$7.52M 5.26% 4
2016
Q2
$74.7M Buy
895,271
+4,776
+0.5% +$424K 5.61% 2
2016
Q1
$81.8M Buy
890,495
+34,434
+4% +$3.11M 6.26% 2
2015
Q4
$86.6M Buy
856,061
+61,455
+8% +$6.39M 6.52% 1
2015
Q3
$78M Buy
794,606
+31,154
+4% +$3.46M 6.24% 2
2015
Q2
$89.4M Buy
763,452
+123,984
+19% +$13.5M 6.62% 1
2015
Q1
$62.8M Sell
639,468
-5,548
-0.9% -$563K 4.5% 7
2014
Q4
$60.8M Buy
645,016
+112,926
+21% +$11.7M 4.2% 6
2014
Q3
$56.6M Buy
532,090
+108,111
+25% +$10.6M 3.9% 6
2014
Q2
$35.2M Buy
423,979
+267,129
+170% +$20.8M 2.3% 13
2014
Q1
$11.1M Buy
156,850
+650
+0.4% +$51K 0.53% 41
2013
Q4
$11.7M Buy
+156,200
New +$10.9M 0.6% 36

Other funds holding GILD

Waverton Investment Management's GILD Position: Q4 2025 in Review

Waverton Investment Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,000 shares — an estimated $222K sold.

Waverton Investment Management first reported a position in GILD in Q4 2013 and held it in 21 quarters. The position peaked at $89.4M in Q2 2015. 2,225 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Waverton Investment Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Waverton Investment Management sold 2,000 Gilead Sciences shares in Q4 2025, an estimated $222K.
  • Waverton Investment Management first reported a position in Gilead Sciences in Q4 2013 and held it in 21 quarters.
  • Waverton Investment Management's Gilead Sciences position peaked at $89.4M in Q2 2015.
  • 2,225 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Waverton Investment Management's 13F filing for Q4 2025.